AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...

AstraZeneca ( NASDAQ: AZN) said that the late-stage trial for its medication Fasenra (benralizumab) in patients suffering ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and ...

A major global study published in The Lancet has found that while deaths from chronic diseases such as cancer, heart disease, ...

AstraZeneca (AZN) announced on Wednesday that its late-stage trial of Fasenra in patients with chronic obstructive pulmonary ...

Study findings suggest BMI may be crucial in the prognosis and optimal management of CAP among patients with NTM-PD.

For adults with a history of smoking undergoing low-dose CT for lung cancer screening, emphysema is predictive of mortality up to 25 years.

The multi-billion, multi-year investment comes as many of GSK’s pharma peers pull away from the U.K., either suspending or ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” second-quarter 2025 investor letter. A ...

Since 2020, at least 270 people in Maricopa County have died at home from heat-related causes when their cooling systems ...